These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 12815953)
21. Ha-Ras(G12V) induces senescence in primary and immortalized human esophageal keratinocytes with p53 dysfunction. Takaoka M; Harada H; Deramaudt TB; Oyama K; Andl CD; Johnstone CN; Rhoades B; Enders GH; Opitz OG; Nakagawa H Oncogene; 2004 Sep; 23(40):6760-8. PubMed ID: 15273725 [TBL] [Abstract][Full Text] [Related]
22. Oncogenic Ras blocks transforming growth factor-beta-induced cell-cycle arrest by degradation of p27 through a MEK/Erk/SKP2-dependent pathway. Schepers H; Wierenga AT; Eggen BJ; Vellenga E Exp Hematol; 2005 Jul; 33(7):747-57. PubMed ID: 15963850 [TBL] [Abstract][Full Text] [Related]
23. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis. Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133 [TBL] [Abstract][Full Text] [Related]
24. The transforming oncoproteins determine the mechanism by which p53 suppresses cell transformation: pRb-mediated growth arrest or apoptosis. Hansen R; Reddel R; Braithwaite A Oncogene; 1995 Dec; 11(12):2535-45. PubMed ID: 8545110 [TBL] [Abstract][Full Text] [Related]
25. Expression of the tumor suppressor ARHI inhibits the growth of pancreatic cancer cells by inducing G1 cell cycle arrest. Lu X; Qian J; Yu Y; Yang H; Li J Oncol Rep; 2009 Sep; 22(3):635-40. PubMed ID: 19639215 [TBL] [Abstract][Full Text] [Related]
26. Radiation response and cell cycle regulation of p53 rescued malignant keratinocytes. Niemantsverdriet M; Jongmans W; Backendorf C Exp Cell Res; 2005 Oct; 310(1):237-47. PubMed ID: 16120440 [TBL] [Abstract][Full Text] [Related]
27. Immortalized fibroblasts from NF-kappaB RelA knockout mice show phenotypic heterogeneity and maintain increased sensitivity to tumor necrosis factor alpha after transformation by v-Ras. Gapuzan ME; Schmah O; Pollock AD; Hoffmann A; Gilmore TD Oncogene; 2005 Sep; 24(43):6574-83. PubMed ID: 16027734 [TBL] [Abstract][Full Text] [Related]
36. [Expression of p53 and ras p21 gene products in malignant transformed V79 cell induced by various organic components of DEPs]. Lü Y; Ding X; Ye S Wei Sheng Yan Jiu; 1998 Jul; 27(4):224-6. PubMed ID: 10682588 [TBL] [Abstract][Full Text] [Related]
39. A mutant p53 protein is required for maintenance of the transformed phenotype in cells transformed with p53 plus ras cDNAs. Zambetti GP; Olson D; Labow M; Levine AJ Proc Natl Acad Sci U S A; 1992 May; 89(9):3952-6. PubMed ID: 1570319 [TBL] [Abstract][Full Text] [Related]
40. Resistance to DNA-damaging agents is discordant from experimental metastatic capacity in MEF ras-transformants-expressing gain of function MTp53. Bristow RG; Peacock J; Jang A; Kim J; Hill RP; Benchimol S Oncogene; 2003 May; 22(19):2960-6. PubMed ID: 12771947 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]